New preparation of [123I]PE2I:: investigation of the oxidation and purification steps

被引:4
作者
Berthommier, E
Loc'h, C
Chalon, S
Olivier, C
Emond, P
Boulanger, HD
Lelait, MA
Mauclaire, L
机构
[1] Univ Tours, Lab Biophys Med & Pharmaceut, INSERM U316, F-37200 Tours, France
[2] CEA, Serv Hosp Frederic Joliot, DRM, F-91406 Orsay, France
[3] CIS Bio Int, F-91192 Gif Sur Yvette, France
关键词
I-123; PE2I; cocaine analogue; radiolabelling; iodogen; hydrogen peroxide; SPECT;
D O I
10.1002/jlcr.620
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In order to simplify preparation of [I-123]PE2I, iodogen and hydrogen peroxide were examined as oxidants for the preparation of radioiodinated PE2I, e.g. (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl) nortropane). Among the oxidizing compounds assayed, iodogen appears to afford the best results for this purpose (high radiochemical yield, high chemical purity and a reasonable reaction time). A simplified and efficient method is described here for the preparation of [I-123]PE2I based on the exchange of a I-123 tributyl tin analogue in oxidative conditions followed by purification by solid phase extraction (SPE). Using this method, [I-123]PE2I was obtained with a radiopharmaceutical yield over 60%, with chemical and radiochemical purities higher than 95% without the addition of a carrier ((NaI)-I-127) (2G Bq/nmol) or with a specific activity adjusted to 85-90 MBq/nmol in the presence of the carrier. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:1019 / 1028
页数:10
相关论文
共 14 条
[1]   LOSS OF DOPAMINE UPTAKE SITES LABELED WITH [H-3] GBR-12935 IN ALZHEIMERS-DISEASE [J].
ALLARD, P ;
ALAFUZOFF, I ;
CARLSSON, A ;
ERIKSSON, K ;
ERICSON, E ;
GOTTFRIES, CG ;
MARCUSSON, JO .
EUROPEAN NEUROLOGY, 1990, 30 (04) :181-185
[2]  
Asenbaum S, 1997, J NUCL MED, V38, P1
[3]  
Booij J, 1998, J NUCL MED, V39, P1879
[4]   Synthesis and ligand binding of nortropane derivatives: N-substituted 2 beta-carbomethoxy-3 beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2 beta-carbomethoxy-3 beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter [J].
Emond, P ;
Garreau, L ;
Chalon, S ;
Boazi, M ;
Caillet, M ;
Bricard, J ;
Frangin, Y ;
Mauclaire, L ;
Besnard, JC ;
Guilloteau, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) :1366-1372
[5]   Exploration of the dopamine transporter:: In vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) [J].
Guilloteau, D ;
Emond, P ;
Baulieu, JL ;
Garreau, L ;
Frangin, Y ;
Pourcelot, L ;
Mauclaire, L ;
Besnard, JC ;
Chalon, S .
NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (04) :331-337
[6]  
Halldin C, 1996, SYNAPSE, V22, P386, DOI 10.1002/(SICI)1098-2396(199604)22:4<386::AID-SYN10>3.0.CO
[7]  
2-W
[8]  
Helfenbein J, 1999, J LABELLED COMPD RAD, V42, P581
[9]   A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: Pharmacological evaluation and PET experiments [J].
Helfenbein, J ;
Loc'h, C ;
Bottlaender, M ;
Emond, P ;
Coulon, C ;
Ottaviani, M ;
Fuseau, C ;
Chalon, S ;
Guenther, I ;
Besnard, JC ;
Frangin, Y ;
Guilloteau, D ;
Maziere, B .
LIFE SCIENCES, 1999, 65 (25) :2715-2726
[10]  
JENKINS ID, 1971, J AM CHEM SOC, V93, P4323